Compumedics Limited (ASX:CMP) is pleased to announce it has secured a new $1.0 million (USD 0.75 million) contract to supply a major US-based hospital group with its Grael(TM) and Neuvo(R) EEG neurology systems.
Compumedics Limited (ASX:CMP) Up-dated May 2015 Corporate Presentation including an Investor overview.
Rhinomed (ASX:RNO) is pleased to announce it has continued to expand its Australian wholesale pharmacy distribution footprint with Sigma Pharmaceuticals Limited (ASX:SIP) to wholesale its Mute™ snoring and sleep quality technology.
Rhinomed (ASX:RNO) is pleased to announce it has seen strong progress in the commercialisation of its nasal technology platform during FY15Q3.
Compumedics Limited (ASX:CMP) announce the Broker Presentation for May 2015 with significant highlights.
Rhinomed (ASX:RNO) presented the keynote address titled 'Changing the Way the World Breathes' at the 2015 Master Investor Show, held in London on 25th April 2015.
Regeneus (ASX:RGS), a clinical stage regenerative medicine company focused on the development of cell therapies, announced today that it has received ethics approval for a clinical trial of its new off-the-shelf allogeneic stem cell treatment, known as Progenza, for patients with knee osteoarthritis.
